CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 418 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03640234
NCT03640234N/ACompleted
CompareCT.gov

Return of Actionable Variants Empirical (RAVE) Study

Mayo Clinic·observational·Posted Aug 21, 2018·Updated Sep 27, 2022

In Brief

An observational study for Familial Hypercholesterolemia. Completed, enrolled 418 participants.

Detailed Summary

This is a genomic implementation project with ancillary studies to understand the impact on patients' health and well-being of returning genomic results to them and depositing those results in the medical record.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFamilial Hypercholesterolemia
Countries--
CollaboratorsNational Institutes of Health (NIH), National Human Genome Research Institute (NHGRI)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 21, 2018
Enrollment StartFeb 25, 2016
Primary CompletionSep 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 7.9 years ago